Skip to main content
Resources & Evidence Contact us

Transforming care for vulnerable babies by unlocking the power of human milk

How it works

Transforming care for vulnerable babies by unlocking the power of human milk

How it works

Proven and published in over 20 clinical studies


Setting the bar at state of the art

Operating the world’s first pharmaceutical-grade human milk processing facilities, we utilise vat pasteurisation and a patented manufacturing process to retain the highest levels of essential bioactive components while ensuring pathogen inactivation.8

Lonnerdal B. Bioactive proteins in human milk-potential benefits for preterm infants. Clin Preinatol. 2017;44(1):179-191. doi:10.1016/j.clp.2016.11.013

Read about our quality & safety

Stay current

Get the latest human milk nutrition news and research

Sign up for our newsletter


Unlock the power of human milk

Bring Prolacta products into your NICU

  • 1

    Identify desired clinical outcomes – such as reducing the incidence of bronchopulmonary dysplasia – and the anticipated economic outcomes

  • 2

    Get in contact with us to determine an optimal feeding protocol, as well as support for coding, billing, and reimbursement

  • 3

    Prepare your facility with implementation, staff training and parent education

What parents need to know…

NEC risk for premature infants

Recent lawsuits about cow milk-based nutrition used in NICUs and the life-threatening intestinal disease called NEC have worried many parents. Prolacta Bioscience isn't involved in any of these lawsuits, but the matter has highlighted why our 100% human milk-based nutrition is beneficial for the tiniest preemies.

Learn more

Ready to help with anything you need

Ready to help with anything you need

Doctor-to-doctor guidance

Finding my sales representative

Support with an existing order

Getting products for my baby

Donating my milk

Citations

1 Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet [published correction appears in Breastfeed Med. 2017;12(10):663]. Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134

2 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

3 Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

4 Bergner EM, Shypailo R, Visuthranukul C, et al. Growth, body composition, and neurodevelopmental outcomes at 2 years among preterm infants fed an exclusive human milk diet in the neonatal intensive care unit: a pilot study. Breastfeed Med. 2020;15(5):304-311. doi:10.1089/bfm.2019.0210

5 Hair AB, Bergner EM, Gollins LA, et al. Long-term outcomes at 2 and 5 years from the randomized controlled trial: human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in VLBW infants. Poster presented at: Pediatric Academic Societies Meeting. April 24 – May 1, 2019. Baltimore, MD.

6 Fleig L, Hagan J, Lee ML, Abrams SA, Hawthorn KM, Hair AB. Growth outcomes of small for gestational age preterm infants before and after implementation of an exclusive human milk-based diet. J Perinatol. 2021:41(8):1859-1864. doi:10.1038/s41372-021-0182-x

7 Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459. doi:10.1186/1756-0500-6-459

8 Lonnerdal B. Bioactive proteins in human milk-potential benefits for preterm infants. Clin Preinatol. 2017;44(1):179-191. doi:10.1016/j.clp.2016.11.013